Hera med australia. In 2022-2023, there were around 166 million GP patient encounters in Australia. Jun 24, 2024 · HeraMED and Telstra Health will also jointly promote the integration of HeraMED into the Smart Connected Care ecosystem through education and marketing to existing and prospective users as part of the Smart Partner Marketing Plan. 02m private placement from three prominent institutional investors Feb 11, 2026 · HeraMED Limited is an Australia-based medical data and technology company. Feb 25, 2025 · Australian medtech company HeraMED is to partner with smartwatch giant Garmin to integrate Garmin data into HeraMED’s clinical grade remote monitoring platform HeraCARE. It has been clinically validated for fetal heart rate monitoring for use in home and healthcare settings. The Company is engaged in the digital transformation of maternity care by transforming the prenatal and postpartum Nanocap health software company HeraMED (ASX:HMD) has been slammed on Monday as the company revealed its US based health clinic partner will no longer use HeraMED’s ‘HeraCARE’ software package. HeraMED, the leader in remote prenatal monitoring technology, is publically traded on the ASX and works with leading global healthcare institutions. Special Report: HeraMED has received a boost in its efforts to lead the transformation of maternity care globally, accepting a $1. Apr 5, 2021 · HeraBEAT is a CE certified medical device for fetal and maternal heart rate. Nov 11, 2024 · HeraMED Limited (ASX: HMD), a prominent medical data and technology company focused on digital maternity care, has accepted an investment offer of $1. Jun 24, 2024 · The partnership with Telstra Health’s MedicalDirector platform servicing GP and healthcare professionals, signed in November 2023, marked HeraCARE as the first remote maternity solution to join the Telstra Health digital ecosystem. It is used by pregnant women in Europe, USA, Israel and Australia. Jul 4, 2023 · Explore the latest from HeraMED, the leader in virtual maternity care and remote pregnancy monitoring technology. . Dec 4, 2024 · HeraMED has successfully launched its HeraCARE platform in collaboration with several healthcare providers across the US, Australia, and Europe. Medical data and technology company HeraMED (ASX:HMD) is redefining how pre and post-natal care is delivered and experienced with its medical grade, clinically-validated, end-to Jul 15, 2024 · Melbourne, Australia – 15 July 2024 | Heramed Ltd (ASX: HMD) ("Heramed" or the "Company"), a pioneering medical data and technology company transforming maternity care, is pleased to announce the signing of a five-year Strategic Partnership Agreement (SPA) with the University of Technology Sydney (UTS). Jun 28, 2024 · HeraMED, an Australian listed Israeli medtech company focused on maternity care, has announced the soft launch of HeraCARE within the Telstra Health’s Smart Connected Care ecosystem through targeted GP clinics. HeraMED is an innovative medical data and technology company leading the digital transformation of maternity care. Special Report: HeraMED is on a mission to revolutionise maternity care through digitisation ensuring expectant and new mothers have access to cutting-edge technology for the wellbeing of themselves and their babies. The launch was announced at the RACGP Practice Owners Conference in Cairns, Australia. We are reshaping the prenatal and postpartum experience through our revolutionary remote monitoring platform. HeraMED Limited (ASX: HMD) (‘HeraMED’ or the ‘Company’), a medical data and technology company leading the digital transformation of maternity care, is pleased to provide an update on user growth for pregnant mothers currently using its innovative HeraCARE platform. The integration will mean expectant mothers and their healthcare providers can access a broader range of health metrics such as heart rate, sleep patterns and fitness activity levels. HeraMED supports rural providers with remote monitoring and virtual care capabilities that expand women’s health access while optimizing limited clinical resources. The platform provides improved care outcomes, increased productivity for healthcare providers, and enhanced patient satisfaction. Oct 14, 2024 · Special Report: HeraMED is on a mission to revolutionise maternity care through digitisation ensuring expectant and new mothers have access to cutting-edge technology for the wellbeing of Oct 8, 2024 · Special Report: Medical data and technology company HeraMED has reported a new record number of active and accumulated users or mums on its HeraCARE platform, which remotely monitors pregnancies. 02 million (before costs) through a private placement from three institutional investors, marking another significant capital raise for the company. Oct 16, 2025 · HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. These will integrate into HeraMD’s HeraMED is advancing discussions with the Therapeutic Goods Administration (TGA) to reinstate its HeraBEAT foetal heart rate monitor for at-home use. If approved, the device could become the only foetal doppler available for home use in Australia. gvrw amvw pfstcjs ugog jyprjr ygd tpehwxoe gnyanrs zhpk nujcd